News

The Manila Times15h
BioClick - an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
Today, eXoZymes Inc. (NASDAQ: EXOZ) ("eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable ...